Alterola Biotech, Inc.
						ABTI
					
					
							
								$0.00
								$0.000.00%
								
							
						OTC PK
					
				Rating
							Reward
									
							Risk
									
							Rating Factors
							Growth Index
									
							Efficiency Index
									
							Solvency Index
									
							Total Return Index
									
							Volatility Index
									
							Dividend Index
									
							Headlines
						There are no news to display.
							Balance Sheet
						Total Assets (Q)
							
						Total Debt (Q)
							
						Total Liabilities (Q)
							
						Book Value Per Share (Q)
							
						Cash Flow
						Cash from Operations (TTM)
							
						Cash from Investing (TTM)
							
						Cash from Financing (TTM)
							
						Net Change in Cash (TTM)
							
						Filings
						Filing Date
							Friday, November 29, 2024
						Period Date
							Monday, September 30, 2024
						Next Filing
							 (est)
						Price History
						Beta
							
						7-Day Total Return
							
						30-Day Total Return
							
						60-Day Total Return
							
						90-Day Total Return
							
						Year to Date Total Return
							
						1-Year Total Return
							
						2-Year Total Return
							
						3-Year Total Return
							
						5-Year Total Return
							--
						52-week Low
							
						52-week High
							
						Valuation
						
						Enterprise Value
							
						Price/Sales (TTM)
							--
						Price/Book (Q)
							
						Dividends and Shares
						Shares Outstanding
							
						Dividend Per Share (Most Recent)
							--
						Dividend Per Share (TTM)
							--
						Corporate Info
						Website
							
						Phone Number
							44 1516 019 477
						Address
							
47 Hamilton Square 
Birkenhead, CH41 5AR
						Birkenhead, CH41 5AR
Country
							
						Year Founded
							--
						Business Description
						Sector
							
						
								
									Alterola Biotech, Inc., a pharmaceutical company, engages in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated...
									more